Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alveolus

Explore full profile

Leader in the emerging field of non-vascular interventional stenting through next generation stent technology

Charlotte, United StatesFounded 2001Health Tech & Medtech
Valuation $50–100M Last recorded · 2006
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Alveolus and the history behind them.

About Alveolus

Alveolus, operating under the brand Merit Medical, is a prominent player in the medical device industry. The company specializes in manufacturing disposable medical devices and surgical kits that are essential in various medical fields such as cardiovascular critical care, endoscopy, interventional oncology, spine, peripheral intervention, and more.

Merit Medical serves a diverse range of clients including hospitals, outpatient facilities, and healthcare professionals who require reliable and high-quality medical devices for patient care. The company operates in the global healthcare market, focusing on providing innovative solutions that enhance patient outcomes and streamline medical procedures.

The business model of Merit Medical revolves around the design, production, and distribution of its medical devices. Revenue is primarily generated through the sale of these devices and surgical kits to healthcare providers worldwide. The company also invests in research and development to continuously improve its product offerings and maintain a competitive edge in the market.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2001
Headquarters
Charlotte, United States
Employees
7
Open positions
None listed
Dealroom signal
24.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Surgery, Patient Care, Respiratory, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
b2b

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Feb 2009 $0 — Undisclosed —
SERIES EEquity / VC Sep 2008 $3.3M $13M EGS Healthcare Capital Partners · ATEL Ventures —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Alveolus website traffic

Latest recorded traffic for Alveolus is 0 monthly website visits. Alveolus's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Epic Airway SystemsChanging the standard of care for elective and emergent airway management, to save lives, time and money, while reducing medication administration and improving patient and practitioner safety Schenectady, United States Operational — $2M $6M
Prana SurgicalInnovative solutions for early lung cancer intervention, enhancing diagnosis, reducing costs, and improving patient outcomes Houston, United States Operational
Noah MedicalNoah Medical's next-generation robotic platform targets early diagnosis and treatment of patients across multiple indications Redwood City, United States Operational
CryosaMedical device company developing novel treatments for obstructive sleep apnea Arden Hills, United States Operational
Dalent MedicalStartup medical device launching an innovative new surgical device for the otolaryngology (ent) Miami, United States Operational
M&S BioticsHealthcare analytics company that is aiming to make surgical procedures more efficient, effective, and safer Scranton, United States Operational
Sadra MedicalFocused on developing minimal invasive alternatives to surgical valve replacement and improve patient care Campbell, United States Acquired
Sinopsys SurgicalMedical devices for surgical procedures of the lacrimal glands Boulder, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • United Ventures
  • Matignon Technologies
  • EGS Healthcare Capital Partners
  • MB Venture Partners
  • FCA Venture Partners
  • MDS Capital

Series B and later2 investors entered at this stage

  • Ridgeback Capital
  • ATEL Ventures

Other known investors2 additional known investors

  • Charleston Angel Partners
  • Lumira Ventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alveolus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alveolus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.